2010 News Releases

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
September 2, 2010  
Oncolytics Biotech® Inc. Announces Randomized Phase II Ovarian Cancer Study to be Conducted by the Gynecologic Oncology Group and Sponsored by the National Cancer Institute

August 5, 2010  
Oncolytics Biotech® Inc. to Present at 30th Annual Canaccord Genuity Growth Conference

July 29, 2010  
Oncolytics Biotech(R)Inc. Announces Second Quarter 2010 Results

July 19, 2010  
Oncolytics Biotech® Inc. Receives No Objection Letter from Health Canada to Conduct Phase 3 Trial of REOLYSIN® in Head and Neck Cancers

June 17, 2010  
Oncolytics Biotech® Inc. Announces Issuance of 35th U.S. Patent

June 7, 2010  
Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the ASCO Annual Meeting.

June 4, 2010  
Oncolytics Biotech® Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting

June 3, 2010  
Oncolytics Biotech® Inc. to Present at the 9th Annual Needham Healthcare Conference

June 1, 2010  
Oncolytics Biotech® Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN® in Head and Neck Cancers

May 26, 2010  
Oncolytics Biotech® Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial

Page 1 Of 3  
Next








Nasdaq Stock Exchange
TSX

 

 
The Company | Technology & Product | Clinical Trials | Investors | FAQ | Contact Us | Home
Oncolytics Biotech Inc. © 2002 All rights reserved. Legal Notice. Privacy Policy.
Maintained and Marketed by Stockgroup